Combining physostigmine with meperidine for sedation and analgesia during colonoscopy

Endoscopy

Volumn 37, Issue 12, 2005, Pages 1205-1210

  Yardeni, I Z ^a,b   Melzer, E ^a   Smolyarenko, V ^a,b   Zeidel, A ^a,b   Chervinsky, A ^a   Binder, Y ^a   Beilin, B ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ONDANSETRON; PETHIDINE; PHYSOSTIGMINE;

ADULT; AGED; ANESTHETIC RECOVERY; ARTERIAL PRESSURE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLONOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; GASTROINTESTINAL DISEASE; HEART RATE; HEMODYNAMICS; HUMAN; INTRAVENOUS REGIONAL ANESTHESIA; MALE; NAUSEA; NOCICEPTION; OUTPATIENT; OXYGEN SATURATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATION DEPRESSION; SEDATION; SIDE EFFECT; SINGLE DRUG DOSE; SWEATING; VISUAL ANALOG SCALE;

ADULT; AGED; AMBULATORY CARE; ANALGESIA; ANALYSIS OF VARIANCE; COLONOSCOPY; COLORECTAL NEOPLASMS; CONSCIOUS SEDATION; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MASS SCREENING; MEPERIDINE; MIDDLE AGED; PAIN MEASUREMENT; PATIENT SATISFACTION; PHYSOSTIGMINE; PROBABILITY; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 28844468542     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-870217     Document Type: Article

References (40)

1. Jamieson J. Anesthesia and sedation in the endoscopy suite: influences and options? Curr Opin Anesthesiol 1999; 12: 417-423
2. Shipley RH, Butt JH, Farbry JE, Horowitz B. Psychological preparation for endoscopy: physiological and behavioral changes in patients with differing coping styles for stress. Gastrointest Endosc 1977; 24: 9-13
3. Rembacken BJ, Axon TR. The role of pethidine in sedation for colonoscopy. Endoscopy 1995; 27: 244-247
4. Chokhavatia S, Nguyen L, Williams R et al. Sedation and analgesia for gastrointestinal endoscopy. Am J Gastroenterol 1993; 88: 393-396
5. O'Connor KW, Jones S. Oxygen desaturation is common and clinically underappreciated during elective endoscopic procedures. Gastrointest Endosc 1990; 36: S2-S4
6. Eckardet VF, Kanzler G, Schmitt T et al. Complications and adverse effects of colonoscopy with selective sedation. Gastrointest Endosc 1999; 49: 560-565
7. Patterson KW, Noonan N, Keeling NW et al. Hypoxemia during outpatient gastrointestinal endoscopy: the effects of sedation and supplemental oxygen. J Clin Anesth 1995; 7: 136-140
8. Practice guidelines for sedation and analgesia by non-anesthesiologists. A report by the American Society of Anesthesiologists Task Force on sedation and analgesia by non-anesthesiologists. Anesthesiology 1996; 84: 459-471
9. Hart R, Classen M. Complications of diagnostic gastrointestinal endoscopy. Endoscopy 1990; 22: 229-233
10. Iber FL, Livak A, Kruss DM. Apnea and cardiopulmonary arrest during and after endoscopy. J Clin Gastroenterol 1992; 14: 109-113
11. Lydic R, Baghdoryan HA. Cholinergic contributions to the control of consciousness. In: Yaksh TL, Lynch C III, Zapole WM et al (eds). Anesthesia: biologic foundation. Philadelphia: Lippincott-Raven, 1997: 33-450
12. Nemirovski A, Niv D. Cholinergic mechanisms and antinociception. Curr Rev Pain 1996; 1: 10-22
13. Snir-Mor I, Weinstock M, Davidson JT, Bahar M. Physostigmine antagonized morphine-induced respiratory depression in human subjects. Anesthesiology 1983; 59: 6-9
14. Craig B, Caldwell CB, Gross JB. Physostigmine reversal of midazolam-induced sedation. Anesthesiology 1982; 57: 125-127
15. Meuret P, Backman SB, Bonhomme V et al. Physostigmine reverses propofol-induced unconsciousness and attenuation of the auditory steady state response and bispectral index in human volunteers. Anesthesiology 2000; 93: 708-717
16. Dripps RD, Lamont A, Eckenhoff JE. The role of anesthesia in surgical mortality. JAMA 1961; 178: 261
17. Palmer T. Anticholinesterase agents. In: Gilman AG, Goodman LG, Gilman A (eds). The pharmacological basis of therapeutics. 6th edn. New York: Macmillan Publising Co. Inc, 1980: 100-119
18. Brievik EK, Skoglund LA. Comparison of present pain intensity assessments on horizontally and vertically oriented visual analogue scales. Methods Find Exp Clin Pharmacol 1998; 20: 719-724
19. Chung F. Discharge criteria: a new trend. Can J Anaesth 1995; 42: 1056-1058
20. Rudner R, Jalowiecki P, Kawecki P et al. Conscious analgesia/sedation with remifentanyl and propofol versus total intravenous anesthesia with fentanyl, midazolam, propofol for outpatient colonoscopy. Gastrointest Endosc 2003; 57: 657-663
21. Lydic R, Keifer JC, Baghdoyan HA, Becker L. Microdialysis of the pontine reticular formation reveals inhibition of acetylcholine release by morphine. Anesthesiology 1993; 79: 1003-1012
22. Takita K, Herlenious E, Yamamoto Y, Lindahl SG. Effects of neuroactive substances on morphine-induced respiratory depression: an in vitro study. Brain Res 2000; 24: 201-205
23. Ge XQ, Xu PC, Bian CF. Relationship between morphine-induced respiratory depression and the cholinergic system of the respiratory center. Yao Xue Xue Bao 1990; 25: 566-572
24. Berkenbosch A, Olievier CN, Wolsink JG et al. Effects of morphine and physostigmine on ventilatory response to carbon dioxide. Anesthesiology 1994; 80: 1303-1310
25. Hedner J, Kraiczi H, Peker Y, Murphy P. Reduction of sleep-disordered breathing after physostigmine. Am J Respir Crit Care Med 2003; 168: 1246-1251
26. Sitaram N, Buchsbaum MS, Gillin JC. Physostigmine analgesia and somatosensory-evoked responses in man. Eur J Pharmacol 1977; 42: 285-290
27. Weinstock M, Davidson JT, Schnieden R, Schnieden H. Effect of physostigmine on morphine-induced postoperative pain and somnolence. Br J Anaesth 1982; 54: 429-433
28. Petersson J, Gordh TE, Hartvig P, Wiklund L. A double-blind trial of the analgesic properties of physostigmine in postoperative patients. Acta Anaesthesiol Scand 1986; 30: 283-288
29. Patil CS, Kulkarni SK. The morphine-sparing effect of physostigmine. Methods Find Exp Clin Pharmacol 1999; 21: 523-527
30. Gage HD, Gage JC, Tobin JR et al. Morphine-induced spinal cholinergic activation: in vivo imaging with positron emission tomography. Pain 2001; 91: 139-145
31. Beilin B, Nemirovsky AY, Zeidel A et al. Systemic physostigmine increases the antinociceptive effect of spinal morphine. Pain 1997; 70: 217-221
32. Beilin B, Bessler H, Papismedov L et al. Continuous physostigmine combined with morphine-based patient-controlled analgesia in the postoperative period. Acta Anaesthesiol Scand 2005; 49: 78-84
33. Hartvig P, Lindstrom B, Pettersson E, Wiklund L. Reversal of postoperative somnolence using a two-rate infusion of physostigmine. Acta Anaesthesiol Scand 1989; 33: 681-685
34. Buccafusco JJ. The role of central cholinergic neurones in the regulation of blood pressure and in experimental hypertension. Pharm Rev 1996; 48: 179-211
35. Rupreht J, Dworacek B. The central anticholinergic syndrome in the postoperative period. In: Nunn JF, Utting JE, Brown BR (eds). General Anaesthesia. 5th edn. London: Butterworth, 1989: 1141-1148
36. Bright E, Roseveare C, Dalgleish D et al. Patient-controlled sedation for colonoscopy: a randomized trial comparing patient-controlled administration of propofol and alfentanil with physician-administered midazolam and pethidine. Endoscopy 2003; 35: 683-687
37. Blouin RT, Conard PE, Gross JB. Time course of ventilatory depression following induction dose of propofol and thiopental. Anesthesiology 1991; 75: 940-944
38. Vohra A, Thomas AN, Harper NJN, Pollard BJ. Non-invasive measurements of cardiac output during induction of anaesthesia and tracheal intubation: thiopentone and propofol compared. Br J Anaesth 1991; 67: 64-68
39. Murdoch JAC, Grant SA, Kenny GNC. Safety of patient-maintained propofol sedation using a target-controlled system in healthy volunteers. Br J Anaesth 2000; 85: 299-301
40. Fassoulaki A, Sarantropoulos C, Derveniotis C. Physostigmine increases the dose of propofol required to induce anaesthesia. Can J Anaesth 1997; 44: 1148-1151